RESEARCH PAPER
Differences in results of breast cancer curative treatment between urban/rural female population in Podlaskie Voivodship of Poland before introduction of the National Cancer Control Programme
 
More details
Hide details
1
Department of Public Health, Medical University, Bialystok, Poland
2
Lubuski College of Public Health, Zielona Gora, Poland
3
National Institute of Public Health – National Institute of Hygiene, Warsaw, Poland
 
Ann Agric Environ Med. 2013;20(1):68–71
KEYWORDS
ABSTRACT
The aim of the study was to evaluate differences in the results of the curative treatment received by women with breast cancer in urban and rural area in Podlaskie Voivodship in 2001-2002 before the introduction of the National Cancer Control Programme. The analysis was based on 449 women with breast cancer, who received curative treatment in years 2001-2002. Relative 5-year survival rates as function of age and stage among urban and rural women population were calculated. The results showed that survival rates in Podlaskie Voivodship among curatively treated women with breast cancer were 81.9% but they differed between urban and rural areas. Patients living in rural areas had much lower survivals than those living in urban areas at local and regional stage of disease. In all age groups considered in the study survivals in rural areas were lower than in urban ones in which survivals were higher in 55-64 age group. These results indicated the necessity intervention in order to increase the access to the health care system and effectiveness of early detection and also improved treatment standards for more disadvantaged rural areas. These results should be also considered in monitoring of the National Cancer Control Programme introduction in Poland in 2006.
 
REFERENCES (29)
1.
Micheli A, Baili P. Information on cancer. In: Coleman MP. (Ed) Responding to the challenge of cancer in Europe. Institute of Public Health of the Republic of Slovenia 2008: 177-189.
 
2.
Berrino F, Capocaccia R. Survival of European cancer patients. In: Coleman MP. (Ed) Responding to the challenge of cancer in Europe. Institute of Public Health of the Republic of Slovenia 2008: 151-175.
 
3.
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer, 2010.
 
4.
Wojciechowska U, Didkowska J, Zatoński W. Nowotwory złośliwe w Polsce w 2008 roku. Centrum Onkologii Instytut im. M. SkłodowskiejCurie, Warszawa 2010.
 
5.
Jassem J. Rak piersi. [In:] Zalecenia postępowania diagnostycznoterapeutycznego w nowotworach złośliwych. Vol. I. Krzakowski M. [ed.]. Onkologia w Praktyce Klinicznej 2007; 3 suppl. C: 179-222.
 
6.
Gericke Ch. Health Systems in Transition: Poland. WHO Regional Office for Europe on behalf of the European Observatory on Health Systems and Policies, Copenhagen 2005.
 
7.
Wojtyniak B, Goryński P. Stan zdrowia ludności Polski. Narodowy Instytut Zdrowia Publicznego – Państwowy Zakład Higieny. Warszawa 2008.
 
8.
International Statistical Classification of Diseases and Health Related Problems: tenth revision – 2nd edition, World Health Organization, Geneva 2004.
 
9.
EUROCARE Working Group: EUROCARE-4 Protocol for EuropeWide Cancer Survival Study. EUROCARE study web-site: http://www. eurocare.it/Portals/0/Protocol... (access: 2009.10.25).
 
10.
TERYT Krajowy Rejestr Urzędowy Podziału Terytorialnego Kraju [Internet]. Główny Urząd Statystyczny: http://www.stat.gov.pl/broker/ access/definitionTree.jspa (access: 2010.02.15).
 
11.
Esteban D, Whelan S, Laudico A, Parkin DM. Manual for Cancer Registry Personnel. International Agency for Research on Cancer, Lyon 1995.
 
12.
Pohar M, Stare J. Making relative survival analysis relatively easy. Comput Biol Med. 2007; 37: 1741-1749.
 
13.
Pohar M, Stare J. Relative survival analysis in R. Comput Programs Biomed. 2006; 81: 272-278.
 
14.
Hakulinen T, Abeywickrama KH. A computer program package for relative survival analysis. Comput Programs Biomed. 1985; 19: 197-207.
 
15.
Micheli A, Capocaccia R, Martinez C, Mugno E, Coebergh J, Baili P, Verdecchia A, Berrino F, Coleman MP. Cancer control in Europe: a proposed set of European cancer health indicators. Eur J Public Health. 2003; 13(suppl. 3): 116-118.
 
16.
Krzyżak M, Maślach D, Bielska-Lasota M, Juczewska M, Rabczenko D, Marcinkowski JT, Szpak A. Breast cancer survival gap between urban and rural female population in Podlaskie Voivodship, Poland, in 2001- 2002. Population study. Ann Agric Environ Med. 2010; 17: 277-282.
 
17.
Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R, the EUROCARE Working Group EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary. Eur J Cancer. 2009; 45: 931–991.
 
18.
Verdecchia A, Mariano Santaquilani M, Sant M. Survival for cancer patients in Europe. Ann Ist Super Sanità. 2009; 45(3): 315-324.
 
19.
Rocznik Statystyczny Województwa Podlaskiego 2002,Urząd Statystyczny w Białymstoku, Białystok 2003.
 
20.
Krzyżak M, Maślach D, Juczewska M, Lasota W, Rabczenko D, Marcinkowski JT, Szpak A. Differences in breast cancer incidence and stage distribution between urban and rural female population in Podlaskie Voivodship, Poland in years 2001-2002. Ann Agric Environ Med. 2010; 17: 159-162.
 
21.
Sant M, Allemani C, Capocaccia R, Hakulinen T, Aareleid T, Coebergh JW, Coleman MP, Grosclaude P, Martinez C, Bell J, Youngson J, Berrino F and EUROCARE Working Group. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer. 2003; 1: 416-422.
 
22.
Główny Urząd Statystyczny: Charakterystyka obszarów wiejskich. Urząd Statystyczny w Olsztynie, Olsztyn 2004.
 
23.
Adams J, White M, Forman D. Are there socioeconomic gradients in stage and grade of breast cancer at diagnosis? Cross sectional analysis of UK cancer registry data. BMJ 2004; 329: 142-143.
 
24.
Carlsen K, Høybye MT, Dalton SO, Tjønneland A. Social inequality and incidence of and survival from breast cancer in a population-based study in Denmark, 1994–2003. Eur J Cancer. 2008; 44: 1996-2002.
 
25.
Kogevinas M, Pearce N, Susser M, Boffetta P. Social Inequalities and Cancer. IARC Scientific Publication No. 138. International Agency for Research on Cancer, Lyon 1997.
 
26.
Mariotto A, Capocaccia R, Verdecchia A, Micheli A, Feuer EJ, Pickle L, Clegg LX. Projecting SEER cancer survival rates to the US: an ecological regression approach. Cancer Causes Control. 2002; 13: 101-111.
 
27.
Menvielle G, Kunst A. Social inequalities in cancer incidence and cancer survival: Lessons from Danish studies. Eur J Cancer. 2008; 44: 1933-1937.
 
28.
Newman LA, Martin IK. Disparities in breast cancer. Curr Probl Cancer. 2007; 31: 134-56.
 
29.
Yu XQ, O’Connell DL, Gibberd RW, Armstrong BK. Assessing the impact of socio-economic status on cancer survival in New South Wales, Australia 1996–2001. Cancer Causes Control. 2008; 19: 1383– 1390.
 
eISSN:1898-2263
ISSN:1232-1966